HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Qing Lan Selected Research

Non-Hodgkin Lymphoma (Lymphosarcoma)

1/2020Lipid Trait Variants and the Risk of Non-Hodgkin Lymphoma Subtypes: A Mendelian Randomization Study.
1/2020Benzene exposure-response and risk of lymphoid neoplasms in Chinese workers: A multicenter case-cohort study.
11/2019Human exposure to trichloroethylene is associated with increased variability of blood DNA methylation that is enriched in genes and pathways related to autoimmune disease and cancer.
10/2019Estimation of Source-Specific Occupational Benzene Exposure in a Population-Based Case-Control Study of Non-Hodgkin Lymphoma.
10/2019Genetic overlap between autoimmune diseases and non-Hodgkin lymphoma subtypes.
1/2018HLA Class I and II Diversity Contributes to the Etiologic Heterogeneity of Non-Hodgkin Lymphoma Subtypes.
1/2017Evaluating Exposure-Response Associations for Non-Hodgkin Lymphoma with Varying Methods of Assigning Cumulative Benzene Exposure in the Shanghai Women's Health Study.
10/2016High-resolution metabolomics of occupational exposure to trichloroethylene.
1/2016Bayes and empirical Bayes methods for reduced rank regression models in matched case-control studies.
10/2015Occupational Exposure to Benzene and Non-Hodgkin Lymphoma in a Population-Based Cohort: The Shanghai Women's Health Study.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Qing Lan Research Topics

Disease

131Neoplasms (Cancer)
04/2022 - 10/2002
85Lung Neoplasms (Lung Cancer)
10/2022 - 01/2004
62Glioma (Gliomas)
05/2022 - 05/2002
51Non-Hodgkin Lymphoma (Lymphosarcoma)
01/2020 - 01/2006
25Carcinogenesis
01/2022 - 05/2008
18Glioblastoma (Glioblastoma Multiforme)
01/2022 - 06/2010
14Leukemia
01/2019 - 06/2005
13Inflammation (Inflammations)
01/2022 - 09/2006
13Lymphoma (Lymphomas)
01/2020 - 04/2007
12Multiple Myeloma
04/2020 - 09/2008
12Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2020 - 01/2006
10Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
01/2020 - 04/2007
10Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
01/2020 - 01/2008
9B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
01/2020 - 04/2007
8Genetic Predisposition to Disease (Genetic Predisposition)
01/2021 - 04/2005
7Ovarian Neoplasms (Ovarian Cancer)
10/2022 - 07/2011
7Aneurysm (Aneurysms)
02/2020 - 01/2006
7B-Cell Lymphoma (Lymphoma, B Cell)
07/2014 - 05/2006
5Stomach Neoplasms (Stomach Cancer)
01/2022 - 03/2005
5Chronic Obstructive Pulmonary Disease (COPD)
09/2013 - 11/2005
4Autoimmune Diseases (Autoimmune Disease)
10/2022 - 08/2014
4Hypoxia (Hypoxemia)
01/2022 - 07/2010
4Obesity
01/2022 - 11/2011
4Adenocarcinoma of Lung
01/2021 - 08/2010
4Kidney Neoplasms (Kidney Cancer)
11/2019 - 08/2012
4Brain Neoplasms (Brain Tumor)
08/2019 - 06/2010
4Pancreatic Neoplasms (Pancreatic Cancer)
11/2018 - 11/2011
4Intracranial Aneurysm (Cerebral Aneurysm)
01/2017 - 01/2006
3Colorectal Neoplasms (Colorectal Cancer)
07/2022 - 05/2017
3Breast Neoplasms (Breast Cancer)
01/2022 - 01/2017
3Hypertension (High Blood Pressure)
01/2022 - 12/2012
3Cardiovascular Diseases (Cardiovascular Disease)
01/2022 - 01/2016
3Acute-On-Chronic Liver Failure
01/2022 - 01/2018
3Mitochondrial Diseases (Mitochondrial Disease)
11/2021 - 05/2014
3Genomic Instability
11/2021 - 10/2006
3Infections
01/2021 - 07/2007
3Neuroblastoma
01/2021 - 01/2019
3Chromosome Aberrations (Chromosome Abnormalities)
01/2020 - 10/2006
3Liver Neoplasms (Liver Cancer)
10/2019 - 10/2016
3Traumatic Brain Injuries (Traumatic Brain Injury)
04/2018 - 03/2017

Drug/Important Bio-Agent (IBA)

47Coal (Coals)IBA
12/2021 - 05/2004
36Biomarkers (Surrogate Marker)IBA
07/2022 - 01/2004
32Proteins (Proteins, Gene)FDA Link
07/2022 - 05/2004
30Benzene (Benzole)IBA
03/2022 - 05/2005
25Biological ProductsIBA
10/2022 - 05/2006
18CarcinogensIBA
10/2021 - 12/2005
15DNA (Deoxyribonucleic Acid)IBA
01/2021 - 01/2005
15CytokinesIBA
04/2020 - 01/2006
14ORALIT (ORS)IBA
01/2022 - 09/2005
14MicroRNAs (MicroRNA)IBA
10/2021 - 03/2012
13SmokeIBA
05/2018 - 07/2002
12Polycyclic Aromatic Hydrocarbons (Polynuclear Aromatic Hydrocarbons)IBA
01/2019 - 11/2004
11Mitochondrial DNA (mtDNA)IBA
06/2017 - 07/2008
10Trichloroethylene (Trichloroethene)IBA
10/2022 - 09/2010
10Messenger RNA (mRNA)IBA
04/2022 - 06/2009
10fu-yuanIBA
12/2021 - 01/2009
9Lobeline (Smokeless)IBA
12/2021 - 11/2008
9Pharmaceutical PreparationsIBA
10/2021 - 10/2002
8alpha-TocopherolFDA Link
12/2014 - 11/2008
8beta Carotene (Betacarotene)FDA Link
12/2014 - 11/2008
7Temozolomide (Temodar)FDA LinkGeneric
05/2022 - 12/2012
7RNA (Ribonucleic Acid)IBA
04/2022 - 03/2013
7Vehicle Emissions (Emissions, Vehicle)IBA
01/2022 - 01/2012
7Long Noncoding RNAIBA
11/2019 - 11/2016
7Interleukin-10 (Interleukin 10)IBA
06/2013 - 01/2006
6SolventsIBA
10/2022 - 01/2009
6Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
11/2018 - 03/2011
5Therapeutic UsesIBA
03/2022 - 10/2002
5CarbonIBA
01/2020 - 04/2007
5NestinIBA
01/2020 - 10/2008
5SuspensionsIBA
11/2018 - 05/2006
5Red Fluorescent ProteinIBA
10/2015 - 12/2012
4Environmental Pollutants (Pollutants, Environmental)IBA
10/2022 - 01/2014
4Tobacco Smoke Pollution (Passive Smoking)IBA
01/2022 - 09/2006
4AntibodiesIBA
12/2021 - 10/2016
4Transcription Factors (Transcription Factor)IBA
01/2021 - 01/2009
4HLA Antigens (Human Leukocyte Antigens)IBA
01/2021 - 03/2011
4Polychlorinated Biphenyls (PCBs)IBA
01/2019 - 03/2007
4Cytochrome P-450 CYP2E1 (CYP2E1)IBA
01/2018 - 11/2009
4Folic Acid (Vitamin M)FDA LinkGeneric
01/2018 - 09/2005
4Green Fluorescent ProteinsIBA
12/2015 - 08/2008
4Reactive Oxygen Species (Oxygen Radicals)IBA
05/2010 - 12/2004
4CaspasesIBA
12/2009 - 04/2007
3InterferonsIBA
01/2022 - 11/2019
3Carrier Proteins (Binding Protein)IBA
01/2022 - 11/2019
3Circular RNAIBA
11/2021 - 01/2020
3Doxorubicin (Adriamycin)FDA LinkGeneric
01/2021 - 08/2013
3ChemokinesIBA
04/2020 - 07/2013
3SootIBA
01/2020 - 10/2016
3ErbB Receptors (EGF Receptor)IBA
11/2019 - 01/2017
3Small Interfering RNA (siRNA)IBA
07/2019 - 01/2008
3MethyltransferasesIBA
01/2019 - 01/2006
3epidermal growth factor receptor VIIIIBA
12/2018 - 03/2016
3HydrogelsIBA
11/2018 - 10/2016
3EnzymesIBA
10/2018 - 04/2005

Therapy/Procedure

19Therapeutics
04/2021 - 10/2002
6Surgical Instruments (Clip)
02/2020 - 01/2006
6Transplantation
01/2016 - 09/2007
4Drug Therapy (Chemotherapy)
01/2021 - 12/2012
4Lasers (Laser)
05/2015 - 01/2004